Catalyst Pharmaceuticals (CPRX) Work In Process (2023 - 2026)

Catalyst Pharmaceuticals' Work In Process history runs 4 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• Quarterly Work In Process fell 34.42% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 34.42% YoY) and the FY2025 annual result came in at $3.9 million, up 12.37% from the prior year.
• Work In Process was $2.8 million for Q1 2026 at Catalyst Pharmaceuticals, down from $3.9 million in the prior quarter.
• Across five years, Work In Process topped out at $5.3 million in Q2 2025 and bottomed at $2.8 million in Q1 2026.
• A 4-year average of $4.1 million and a median of $4.0 million in 2024 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2025 — Work In Process surged 32.89% — and 2026, when it plunged 34.42%.
• Catalyst Pharmaceuticals' Work In Process stood at $4.6 million in 2023, then slipped by 24.67% to $3.4 million in 2024, then increased by 12.37% to $3.9 million in 2025, then retreated by 28.44% to $2.8 million in 2026.
• Business Quant data shows CPRX's Work In Process at $2.8 million in Q1 2026, $3.9 million in Q4 2025, and $4.6 million in Q3 2025.